There is no additional information on this drug.
|
There is no additional information on this drug.
|
|
ARTIFICIAL TEARS (ahr tuh FISH uhl teerz) treats discomfort caused by dry eyes. It works by moisturizing and protecting the outer surface of your eyes.
|
ARTIFICIAL TEARS (ahr tuh FISH uhl teerz) treats discomfort caused by dry eyes. It works by moisturizing and protecting the outer surface of your eyes.
|
|
ARTIFICIAL TEARS (ahr tuh FISH uhl teerz) treats discomfort caused by dry eyes. It works by moisturizing and protecting the outer surface of your eyes.
|
ARTIFICIAL TEARS (ahr tuh FISH uhl teerz) treats discomfort caused by dry eyes. It works by moisturizing and protecting the outer surface of your eyes.
|
|
There is no additional information on this drug.
|
There is no additional information on this drug.
|
|
There is no additional information on this drug.
|
There is no additional information on this drug.
|
|
ARTIFICIAL TEARS (ahr tuh FISH uhl teerz) treats discomfort caused by dry eyes. It works by moisturizing and protecting the outer surface of your eyes.
|
ARTIFICIAL TEARS (ahr tuh FISH uhl teerz) treats discomfort caused by dry eyes. It works by moisturizing and protecting the outer surface of your eyes.
|
|
There is no additional information on this drug.
|
There is no additional information on this drug.
|
|
There is no additional information on this drug.
|
There is no additional information on this drug.
|
|
REGADENOSON is used to test the heart for coronary artery disease. It is used in patients who can not exercise for their stress test.\n\nThis medicine may be used for other purposes; ask your health care provider or pharmacist if you have questions.
|
REGADENOSON is used to test the heart for coronary artery disease. It is used in patients who can not exercise for their stress test.\n\nThis medicine may be used for other purposes; ask your health care provider or pharmacist if you have questions.
|
|
CASIRIVIMAB; IMDEVIMAB (ka SIR iv' i mab; im DEV i mab) is a monoclonal antibody used to treat COVID-19 in patients who are not hospitalized. It is also used to reduce the risk of getting COVID-19. It is for patients at risk of getting severe symptoms of COVID-19. It may decrease the risk of developing severe symptoms of COVID-19. It may also decrease the chance of going to the hospital. This medication is no longer approved for use by the FDA.
|
CASIRIVIMAB; IMDEVIMAB (ka SIR iv' i mab; im DEV i mab) is a monoclonal antibody used to treat COVID-19 in patients who are not hospitalized. It is also used to reduce the risk of getting COVID-19. It is for patients at risk of getting severe symptoms of COVID-19. It may decrease the risk of developing severe symptoms of COVID-19. It may also decrease the chance of going to the hospital. This medication is no longer approved for use by the FDA.
|
|
Topical wound healing agents treat skin wounds, such as burns and skin ulcers. They work by helping wounds heal. They may also help relieve mild pain and irritation caused by the wound.
|
Topical wound healing agents treat skin wounds, such as burns and skin ulcers. They work by helping wounds heal. They may also help relieve mild pain and irritation caused by the wound.
|
|
Topical wound healing agents treat skin wounds, such as burns and skin ulcers. They work by helping wounds heal. They may also help relieve mild pain and irritation caused by the wound.
|
Topical wound healing agents treat skin wounds, such as burns and skin ulcers. They work by helping wounds heal. They may also help relieve mild pain and irritation caused by the wound.
|
|
There is no additional information on this drug.
|
There is no additional information on this drug.
|
|
There is no additional information on this drug.
|
There is no additional information on this drug.
|
|
There is no additional information on this drug.
|
There is no additional information on this drug.
|
|
METOCLOPRAMIDE (met oh kloe PRA mide) treats reflux disease. It is prescribed when other medications have not worked. It may also be used to treat slow emptying of the digestive tract. It works by helping the muscles in your digestive tract move food. This empties your digestive tract, which relieves symptoms such as fullness, nausea, and heartburn.
|
METOCLOPRAMIDE (met oh kloe PRA mide) treats reflux disease. It is prescribed when other medications have not worked. It may also be used to treat slow emptying of the digestive tract. It works by helping the muscles in your digestive tract move food. This empties your digestive tract, which relieves symptoms such as fullness, nausea, and heartburn.
|
|
PYRIDOSTIGMINE (peer id oh STIG meen) reverses the effects of medications that relax muscles during a procedure. It works by decreasing muscle weakness and loss of movement.
|
PYRIDOSTIGMINE (peer id oh STIG meen) reverses the effects of medications that relax muscles during a procedure. It works by decreasing muscle weakness and loss of movement.
|
|
BECAPLERMIN (be KAP ler min) treats skin ulcers in people with diabetes. It works by promoting wound healing and new skin growth.
|
BECAPLERMIN (be KAP ler min) treats skin ulcers in people with diabetes. It works by promoting wound healing and new skin growth.
|
|
There is no additional information on this drug.
|
There is no additional information on this drug.
|
|
PSYLLIUM (SIL i yum) may support digestion and heart health. It works by increasing the bulk of your stool. This increases pressure, which helps the muscles in your intestine move stool. It also reduces the amount of cholesterol your body absorbs from food.
|
PSYLLIUM (SIL i yum) may support digestion and heart health. It works by increasing the bulk of your stool. This increases pressure, which helps the muscles in your intestine move stool. It also reduces the amount of cholesterol your body absorbs from food.
|
|